Israel Pharmaceuticals and Healthcare Report Q2 2016

Date: April 20, 2016
Pages: 106
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IC29E94DD9BEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Our growth outlook for Israel's pharmaceutical sector is underpinned by the government package to systematically bolster the public health system through targeted investment in health resources and infrastructure. Concerted efforts to grow the interface between private and public medicine and an improving intellectual property picture will ensure commercial opportunities remain for pharmaceutical companies.

Headline Expenditure Projections
  • Pharmaceuticals: ILS7.82bn (USD2.01bn) in 2015 to ILS8.16bn (USD2.11bn) in 2016; +4.3% in local currency terms and +4.6% in US dollar terms. Forecast upgraded from Q116.
  • Healthcare: ILS85.80bn (USD22.09bn) in 2015 to ILS91.29bn (USD23.59bn) in 2016; +6.4% in local currency terms and +6.8% in US dollar terms. Forecast upgraded from Q116.
BMI Industry View
  Table: Headline Pharmaceuticals & Healthcare Forecasts (Israel 2014-2020)
SWOT Analysis
SWOT
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Israel 2012-2020)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Israel 2012-2020)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Israel 2014-2020)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Israel 2014-2020)
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Israel Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
  Table: Price Build-Up In The Israeli Pharmaceutical Market
Reimbursement Regime
Market Overview
Healthcare Sector
  Table: Healthcare Resources (Israel 2010-2015)
  Table: Healthcare Personnel (Israel 2010-2015)
  Table: Healthcare Activity (Israel 2010-2015)
Research & Development
  Table: Israel's R&D Legislation - Conditions For OCS Funding
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
  Table: Multinational Pharmaceutical Company Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Dexcel Pharma
Neopharm Group
Perrigo (Agis Industries)
Taro Pharmaceutical Industries
Teva Pharmaceutical Industries
Demographic Forecast
  Table: Population Headline Indicators (Israel 1990-2025)
  Table: Key Population Ratios (Israel 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Israel 1990-2025)
  Table: Population By Age Group (Israel 1990-2025)
  Table: Population By Age Group % (Israel 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Israel Pharmaceuticals and Healthcare Report Q2 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: